In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $5.76 in the prior trading day, Aspen Aerogels Inc (NYSE: ASPN) closed at $5.69, down -1.22%. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 1.54 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ASPN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 4.22. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 12 ’25 when Young Donald R bought 20,000 shares for $5.35 per share. The transaction valued at 107,000 led to the insider holds 550,856 shares of the business.
Young Donald R sold 63,355 shares of ASPN for $1,902,551 on Sep 30 ’24. The President and CEO now owns 483,640 shares after completing the transaction at $30.03 per share. On Sep 30 ’24, another insider, Donald R. Young, who serves as the President, CEO, Director of the company, bought 134,629 shares for $27.62 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.07 while its Price-to-Book (P/B) ratio in mrq is 1.49.
Stock Price History:
Over the past 52 weeks, ASPN has reached a high of $33.15, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -1.96%, while the 200-Day Moving Average is calculated to be -59.42%.
Shares Statistics:
A total of 82.17M shares are outstanding, with a floating share count of 80.69M. Insiders hold about 1.80% of the company’s shares, while institutions hold 87.85% stake in the company.
Earnings Estimates
A detailed examination of Aspen Aerogels Inc (ASPN) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.05 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.35 and -$0.35 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is $0.34, with 4.0 analysts recommending between $0.84 and -$0.07.
Revenue Estimates
7 analysts predict $72.53M in revenue for the current quarter. It ranges from a high estimate of $74.7M to a low estimate of $70.36M. As of the current estimate, Aspen Aerogels Inc’s year-ago sales were $117.77MFor the next quarter, 7 analysts are estimating revenue of $68.33M. There is a high estimate of $72.3M for the next quarter, whereas the lowest estimate is $64.1M.
A total of 7 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $302.6M, while the lowest revenue estimate was $280.2M, resulting in an average revenue estimate of $292.02M. In the same quarter a year ago, actual revenue was $452.7MBased on 7 analysts’ estimates, the company’s revenue will be $371.13M in the next fiscal year. The high estimate is $419.3M and the low estimate is $335.8M.
